Phase 3 Study Evaluating Safety and Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery
Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of OTX-DP as a sustained release drug (dexamethasone)
depot when placed in the canaliculus of the eyelid for the treatment of post-surgical
inflammation and pain in subjects who have undergone cataract extraction with intra-ocular
lens implantation.